Borosil Scientific cash flow

Latest FY26

Cash from operations: ₹43.3cr−64.0% on FY25
Capital spending: ₹28.5cr+100.9% on FY25
Free cash flow: ₹14.8cr−86.0% on FY25
Cash from financing: −₹6.2cr−₹3.4 cr in FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025

Adjustments to reconcile profit — non-cash items
	—	19.2	18.5
	—	1.1	1.5
	—	−0.3	−0.4
	—	−6.4	−2.5
	—	2.2	0.5
	—	0.1	−0.1
	—	0.9	1.4
	—	−0.6	−0.2
Changes in working capital
	—	−6.7	0.3
	—	−5.2	−9.1
	—	2.1	92.1
	—	7.7	−5.5
	—	0.5	−5.7
Cash from operating activities
	55.4	42.8	40.4
	—	14.7	90.9
	—	57.6	131
	—	14.3	11.3
	—	43.3	120
Cash from investing activities
	—	28.5	14.2
	—	0.9	0.2
	—	39.0	128
	—	29.0	25.0
	—	0.3	1.3
	—	−0.0	−0.1
	—	−37.2	−115
Cash from financing activities
	—	0.2	1.6
	—	0.0	0.8
	—	6.1	3.2
	—	0.4	0.9
	—	1.1	1.5
	—	1.3	−0.0
	—	−6.2	−3.4
	—	−0.1	1.2
	—	−0.0	0.0
	—	−0.1	1.2
Reference items
	68.5	62.2	52.6
	14.1%	13.3%	12.0%
	14.8	14.8	106
	—	7.6	—
	₹1.67	₹1.67	₹11.90
	61.99×	—	—
	—	1.25×	4.49×
	—	14.3	11.3
	—	1.1	1.5

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

BOROSCI₹103.27

Borosil Scientific Limited

· Capital Goods & Defence

₹ CrorePeersSEJALLTDMcap ₹919 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	18.5	19.2	—
+ Finance Costs	1.5	1.1	—
+ Interest Income	-0.4	-0.3	—
+ Fair Value (Gains) / Losses	-2.5	-6.4	—
+ Share-based Payments	0.5	2.2	—
+ Unrealised FX (Gain) / Loss	-0.1	0.1	—
+ Other Non-cash Items	1.4	0.9	—
+ Other — Cash Effects are Investing / Financing	-0.2	-0.6	—
Changes in Working Capital
+ Inventories	0.3	-6.7	—
+ Trade Receivables — Current	-9.1	-5.2	—
+ Other Current Assets	92.1	2.1	—
+ Trade Payables — Current	-5.5	7.7	—
+ Other Current Liabilities	-5.7	0.5	—
Cash from Operating Activities
Profit Before Tax (per I/S)	40.4	42.8	55.4
+ Total Adjustments (incl. Working Capital)	90.9	14.7	—
Cash from Operations (pre-tax)	131.3	57.6	—
+ Income Taxes Paid	11.3	14.3	—
Cash from Operating Activities	120.0	43.3	—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	14.2	28.5	—
+ Disp of Fixed Assets	0.2	0.9	—
+ Purchase of Investments (Equity / Debt)	127.7	39.0	—
+ Sale of Investments (Equity / Debt)	25.0	29.0	—
+ Interest Received — Investing	1.3	0.3	—
+ Other Inflows / (Outflows) — Investing	-0.1	-0.0	—
Cash from Investing Activities	-115.4	-37.2	—
Cash from Financing Activities
+ Proceeds from Exercise of Stock Options	1.6	0.2	—
+ Proceeds from Borrowings	0.8	0.0	—
+ Repayment of Borrowings	3.2	6.1	—
+ Payment of Lease Liabilities	0.9	0.4	—
+ Interest Paid	1.5	1.1	—
+ Other Inflows / (Outflows) — Financing	-0.0	1.3	—
Cash from Financing Activities	-3.4	-6.2	—
Net Changes in Cash (pre-FX)	1.2	-0.1	—
+ Effect of FX Rate Changes on Cash	0.0	-0.0	—
Net Changes in Cash	1.2	-0.1	—
Reference Items
EBITDA	52.6	62.2	68.5
EBITDA Margin %	11.99	13.31	14.08
Free Cash Flow (CFO − Capex)	105.9	14.8	14.8
Free Cash Flow to Equity	—	7.6	—
Free Cash Flow per Basic Share	11.90	1.67	1.67
Price to Free Cash Flow	—	—	61.99
Cash Flow to Net Income	4.49	1.25	—
Cash Paid for Taxes	11.3	14.3	—
Cash Paid for Interest	1.5	1.1	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.